Initial Statement of Beneficial Ownership (3)
June 17 2020 - 3:24PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
Mendis Roshan |
2. Date of Event Requiring Statement (MM/DD/YYYY)
6/8/2020
|
3. Issuer Name and Ticker or Trading Symbol
Sabre Corp [SABR]
|
|
(Last)
(First)
(Middle)
C/O SABRE CORPORATION, 3150 SABRE DRIVE |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
Executive Vice President / |
|
(Street)
SOUTHLAKE, TX 76092
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4) | 2. Amount of Securities Beneficially Owned
(Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) | 4. Nature of Indirect Beneficial Ownership
(Instr. 5) |
| Common Stock | 53369 (1) | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4) | 2. Date Exercisable and Expiration Date
(MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) | 6. Nature of Indirect Beneficial Ownership
(Instr. 5) |
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
| Options to Purchase Common Stock | (2) | 3/13/2025 | Common Stock | 13626.0 | $22.15 | D | |
| Options to Purchase Common Stock | (3) | 3/15/2026 | Common Stock | 11915.0 | $27.79 | D | |
| Options to Purchase Common Stock | (4) | 3/15/2027 | Common Stock | 19350.0 | $22.01 | D | |
| Options to Purchase Common Stock | (5) | 3/15/2028 | Common Stock | 22840.0 | $22.03 | D | |
| Options to Purchase Common Stock | (6) | 3/15/2029 | Common Stock | 17375.0 | $21.35 | D | |
| Options to Purchase Common Stock | (7) | 3/13/2030 | Common Stock | 27027.0 | $8.33 | D | |
| Explanation of Responses: |
| (1) | Includes a grant of 16,484 restricted share unit awards on 9/15/2017 that will vest 100% on 9/15/2020, subject to the reporting person's continued employment on the vesting date. |
| (2) | The options vest and become exercisable as to 25% of the shares of Common Stock of the Issuer subject to each such option on the first anniversary of the date of grant of March 13, 2015 and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to the reporting person's continued employment with the Issuer through each vesting date. |
| (3) | The options vest and become exercisable as to 25% of the shares of Common Stock of the Issuer subject to each such option on the first anniversary of the date of grant of March 15, 2016 and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to the reporting person's continued employment with the Issuer through each vesting date. |
| (4) | The options vest and become exercisable as to 25% of the shares of Common Stock of the Issuer subject to each such option on the first anniversary of the date of grant of March 15, 2017 and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to the reporting person's continued employment with the Issuer through each vesting date. |
| (5) | The options vest and become exercisable as to 25% of the shares of Common Stock of the Issuer subject to each such option on the first anniversary of the date of grant of March 15, 2018 and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to the reporting person's continued employment with the Issuer through each vesting date. |
| (6) | The options vest and become exercisable as to 25% of the shares of Common Stock of the Issuer subject to each such option on the first anniversary of the date of grant of March 15, 2019 and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to the reporting person's continued employment with the Issuer through each vesting date. |
| (7) | The options were granted on March 13, 2020 and vest and become exercisable in three equal installments of 33 1/3% on March 15, 2021, March 15, 2022 and March 15, 2023, subject to the reporting person's continued employment with the Issuer through each vesting date. |
Reporting Owners
|
| Reporting Owner Name / Address | Relationships |
| Director | 10% Owner | Officer | Other |
Mendis Roshan
C/O SABRE CORPORATION
3150 SABRE DRIVE
SOUTHLAKE, TX 76092 |
|
| Executive Vice President |
|
Signatures
|
| /s/ Steve Milton, as attorney-in-fact for Roshan Mendis | | 6/17/2020 |
| **Signature of Reporting Person | Date |
Sabre (NASDAQ:SABR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sabre (NASDAQ:SABR)
Historical Stock Chart
From Jul 2023 to Jul 2024
